Status:
UNKNOWN
Compassionate Use of Hyperbaric Oxygen Therapy
Lead Sponsor:
SerenaGroup, Inc.
Collaborating Sponsors:
SerenaGroup Research Foundation
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational patient registry of COVID-19 patients treated with HBOT.
Detailed Description
The retrospective analysis will focus on the reduction in need for mechanical ventilation in COVID-19 patients. The information will be gathered prospectively. Data will be collected from the patients...
Eligibility Criteria
Inclusion
- Adult patients with COVID-19.
- The clinical decision to use HBOT is independent of the decision to participate in registry.
- A signed and dated informed consent form for the off-label use of Hyperbaric Oxygen Therapy specific to the institution where treatment is rendered.
- Subject is willing and able to comply with instructions and scheduled visits.
Exclusion
- The Subject has other concurrent conditions that in the opinion of the Investigator may compromise patient safety.
- The patient has an untreated pneumothorax.
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 11 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04386265
Start Date
April 15 2020
End Date
May 11 2022
Last Update
October 23 2020
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
White River Wound Healing Center
Batesville, Arkansas, United States, 72501
2
Community Hospital
Monterey, California, United States, 93940
3
Innovative Healing Systems
Tampa, Florida, United States, 33614
4
Decatur Memorial Hospital
Decatur, Indiana, United States, 47240